These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 29082648

  • 1. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D, Sansas B, Jiang JH, Gong QM, Jin GD, Calais V, Yu DM, Zhu MY, Wei D, Zhang DH, Inchauspé G, Zhang XX, Zhu R.
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS, Vorup-Jensen T, Leutscher PD, Erikstrup C, Petersen E.
    BMC Immunol; 2015 Nov 02; 16():65. PubMed ID: 26526193
    [Abstract] [Full Text] [Related]

  • 3. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
    Martin P, Dubois C, Jacquier E, Dion S, Mancini-Bourgine M, Godon O, Kratzer R, Lelu-Santolaria K, Evlachev A, Meritet JF, Schlesinger Y, Villeval D, Strub JM, Van Dorsselaer A, Marchand JB, Geist M, Brandely R, Findeli A, Boukhebza H, Menguy T, Silvestre N, Michel ML, Inchauspé G.
    Gut; 2015 Dec 02; 64(12):1961-71. PubMed ID: 25429051
    [Abstract] [Full Text] [Related]

  • 4. Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.
    Godon O, Evlachev A, Bourgine M, Meritet JF, Martin P, Inchauspe G, Michel ML.
    Vaccine; 2015 Aug 26; 33(36):4548-53. PubMed ID: 26209840
    [Abstract] [Full Text] [Related]

  • 5. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, Yoshida EM, Trinh H, Rodell TC, Laccabue D, Alfieri A, Brillo F, Fisicaro P, Acerbi G, Pedrazzi G, Andreone P, Cursaro C, Margotti M, Santoro R, Piazzolla V, Brunetto MR, Coco B, Cavallone D, Zhao Y, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Massetto B, Fung S, Ahn SH, Ma X, Mangia A, Ferrari C.
    Gastroenterology; 2019 Jul 26; 157(1):227-241.e7. PubMed ID: 30930022
    [Abstract] [Full Text] [Related]

  • 6. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM, Chen S, Al-Mahtab M, Abe M, Hiasa Y, Onji M.
    Antiviral Res; 2012 Oct 26; 96(1):59-64. PubMed ID: 22884884
    [Abstract] [Full Text] [Related]

  • 7. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J, Leroy V, Dufeu-Duchesne T, Larrat S, Richard MJ, Zoulim F, Plumas J, Aspord C.
    Hepatology; 2012 Nov 26; 56(5):1706-18. PubMed ID: 22707082
    [Abstract] [Full Text] [Related]

  • 8. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ, Chen XF, Chen WL, Chen R, Huang J, Luo XD, Liao JY, Chen XP.
    Eur Rev Med Pharmacol Sci; 2017 Oct 26; 21(20):4675-4679. PubMed ID: 29131246
    [Abstract] [Full Text] [Related]

  • 9. Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients.
    Dammermann W, Bentzien F, Stiel EM, Kühne C, Ullrich S, Schulze Zur Wiesch J, Lüth S.
    J Transl Med; 2015 May 13; 13():157. PubMed ID: 25968473
    [Abstract] [Full Text] [Related]

  • 10. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
    Wang Q, Sachse P, Semmo M, Lokhande M, Montani M, Dufour JF, Zoulim F, Klenerman P, Semmo N.
    J Viral Hepat; 2015 Dec 13; 22(12):1068-78. PubMed ID: 26075501
    [Abstract] [Full Text] [Related]

  • 11. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
    Zhuo M, Song L, Tang Y, Dai S, Chen X, Yu Y, Zang G, Tang Z.
    Mol Med Rep; 2015 Sep 13; 12(3):3591-3598. PubMed ID: 26004262
    [Abstract] [Full Text] [Related]

  • 12. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP, Yan HP, Zhang YH, Feng X, Zhao Y, Liao HY, Liu YM, Chen Y, Tan YF, Liu Y.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug 13; 43(8):690-4. PubMed ID: 20021848
    [Abstract] [Full Text] [Related]

  • 13. Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides.
    Yamamiya D, Mizukoshi E, Kaji K, Terashima T, Kitahara M, Yamashita T, Arai K, Fushimi K, Honda M, Kaneko S.
    PLoS One; 2018 Aug 13; 13(6):e0198264. PubMed ID: 29856876
    [Abstract] [Full Text] [Related]

  • 14. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
    Li RB, Chen HS, Xie Y, Fei R, Cong X, Fan CL, Wang SX, Wei L, Wang Y.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct 13; 11(10):588-91. PubMed ID: 14572332
    [Abstract] [Full Text] [Related]

  • 15. Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
    Bruder Costa J, Dufeu-Duchesne T, Leroy V, Bertucci I, Bouvier-Alias M, Pouget N, Brevot-Lutton O, Bourliere M, Zoulim F, Plumas J, Aspord C, ANRS HB06 PEGAN study group.
    PLoS One; 2016 Oct 13; 11(6):e0158297. PubMed ID: 27348813
    [Abstract] [Full Text] [Related]

  • 16. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S, Zhuo M, Song L, Chen X, Yu Y, Zang G, Tang Z.
    Immunobiology; 2016 Jul 13; 221(7):813-21. PubMed ID: 26874581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H, Luo H, Wan X, Fu X, Mao Q, Xiang X, Zhou Y, He W, Zhang J, Guo Y, Tan W, Deng G.
    J Hepatol; 2020 Jan 13; 72(1):45-56. PubMed ID: 31499130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.